BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moss SF, Malfertheiner P. Helicobacter and gastric malignancies. Helicobacter 2007;12 Suppl 1:23-30. [PMID: 17727457 DOI: 10.1111/j.1523-5378.2007.00539.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Eskuri M, Kemi N, Helminen O, Huhta H, Kauppila JH. Toll-like receptors 3, 7, 8, and 9 in gastric cancer. APMIS 2023;131:92-9. [PMID: 36271773 DOI: 10.1111/apm.13281] [Reference Citation Analysis]
2 Qu P, Liu X, Xia X, Xie X, Luo J, Cheng S, Chi J, Liu P, Li H, Zhao W, Yang H, Xu C. Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study. Front Cell Infect Microbiol 2022;12:903002. [DOI: 10.3389/fcimb.2022.903002] [Reference Citation Analysis]
3 Sáenz JB. Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia's Pattern of Spread Throughout the Stomach. Front Cell Dev Biol 2021;9:741574. [PMID: 34869328 DOI: 10.3389/fcell.2021.741574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kim SE, Jung H, Kang SJ, Lee YC, Yang H, Park S, Shin CM, Lim HC, Kim J, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M, Korean College of Helicobacter and Upper Gastrointesinal Research. A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis. Korean J Helicobacter Up Gastrointest Res 2021;21:48-58. [DOI: 10.7704/kjhugr.2020.0052] [Reference Citation Analysis]
5 Khalil M, Przespolewski AC, Segal BH. Malignancies in immune deficiencies. Stiehm's Immune Deficiencies 2020. [DOI: 10.1016/b978-0-12-816768-7.00051-x] [Reference Citation Analysis]
6 Pokhrel N, Khanal B, Rai K, Subedi M, Bhattarai NR. Application of PCR and Microscopy to Detect Helicobacter pylori in Gastric Biopsy Specimen among Acid Peptic Disorders at Tertiary Care Centre in Eastern Nepal. Can J Infect Dis Med Microbiol 2019;2019:3695307. [PMID: 30867850 DOI: 10.1155/2019/3695307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Swain S, Roe MM, Sebrell TA, Sidar B, Dankoff J, VanAusdol R, Smythies LE, Smith PD, Bimczok D. CD103 (αE Integrin) Undergoes Endosomal Trafficking in Human Dendritic Cells, but Does Not Mediate Epithelial Adhesion. Front Immunol 2018;9:2989. [PMID: 30622531 DOI: 10.3389/fimmu.2018.02989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pecoraro A, Nappi L, Crescenzi L, D'Armiento FP, Genovese A, Spadaro G. Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the Literature. J Clin Immunol. 2018;38:67-76. [PMID: 29138951 DOI: 10.1007/s10875-017-0461-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
9 Tak Manesh A, Azizi G, Heydari A, Kiaee F, Shaghaghi M, Hossein-Khannazer N, Yazdani R, Abolhassani H, Aghamohammadi A. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol (Madr) 2017;45:602-15. [PMID: 28411962 DOI: 10.1016/j.aller.2017.01.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
10 Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
11 Wongphutorn P, Samerpitak K, Khuntikeo N, Sawadpanich K, Boonyanugomol W, Chomvarin C. Application of vacA Sequencing in Helicobacter pylori for Classification of Specimens from Healthy Persons, and from Hepatobiliary and Gastroduodenal Patients. J PURE APPL MICROBIO 2017;11:01-07. [DOI: 10.22207/jpam.11.1.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066 [PMID: 28246480 DOI: 10.3748/wjg.v23.i6.1059] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
13 Chang JY, Shim KN, Tae CH, Lee KE, Lee J, Lee KH, Moon CM, Kim SE, Jung HK, Jung SA. Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. BMC Gastroenterol 2017;17:16. [PMID: 28109257 DOI: 10.1186/s12876-017-0579-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
14 UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-A720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
15 Rodriquenz MG, Rossi S, Ricci R, Martini M, Larocca M, Dipasquale A, Quirino M, Schinzari G, Basso M, D'Argento E, Strippoli A, Barone C, Cassano A. Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel "sentinel tumor"? A monoinstitutional, STROBE-compliant observational analysis. Medicine (Baltimore) 2016;95:e4718. [PMID: 27661019 DOI: 10.1097/MD.0000000000004718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
16 Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Seo KI, Lim SK, Jung JK, Kim HJ, Yeo GE, Jeon SC, Cho DS, Han YJ. The Influence of Iron Deficiency onHelicobacter pyloriEradication. Korean J Helicobacter Up Gastrointest Res 2016;16:82. [DOI: 10.7704/kjhugr.2016.16.2.82] [Reference Citation Analysis]
17 Kim SE, Park MI, Park SJ, Moon W, Choi YJ, Cheon JH, Kwon HJ, Ku KH, Yoo CH, Kim JH. Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy. Korean J Intern Med. 2015;30:801-807. [PMID: 26552455 DOI: 10.3904/kjim.2015.30.6.801] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
18 Maker VK, Guzman-arrieta ED. Stomach. Cognitive Pearls in General Surgery 2015. [DOI: 10.1007/978-1-4939-1850-8_12] [Reference Citation Analysis]
19 Rasheed F, Campbell BJ, Alfizah H, Varro A, Zahra R, Yamaoka Y, Pritchard DM. Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. Helicobacter 2014;19:387-99. [PMID: 24827414 DOI: 10.1111/hel.12142] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
20 Vassos N, Agaimy A, Hohenberger W, Croner RS. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications. Int J Surg. 2014;12:371-377. [PMID: 24632413 DOI: 10.1016/j.ijsu.2014.03.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
21 Detková D, Español T. An update on treatment strategies for common variable immunodeficiency. Expert Review of Clinical Immunology 2014;5:381-90. [DOI: 10.1586/eci.09.22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Cai R, Ren G, Wang DB. Synchronous adenocarcinoma and gastrointestinal stromal tumors in the stomach. World J Gastroenterol 2013; 19(20): 3117-3123 [PMID: 23716992 DOI: 10.3748/wjg.v19.i20.3117] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
23 Poursina F, Faghri J, Moghim S, Zarkesh-Esfahani H, Nasr-Esfahani B, Fazeli H, Hasanzadeh A, Safaei HG. Assessment of cagE and babA mRNA expression during morphological conversion of Helicobacter pylori from spiral to coccoid. Curr Microbiol. 2013;66:406-413. [PMID: 23263256 DOI: 10.1007/s00284-012-0280-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
24 Varanat M, Maggi RG, Linder KE, Breitschwerdt EB. Infection of human brain vascular pericytes (HBVPs) by Bartonella henselae. Med Microbiol Immunol 2013;202:143-51. [PMID: 23184416 DOI: 10.1007/s00430-012-0279-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
25 Alfizah H, Ramelah M, Rizal AM, Anwar AS, Isa MR. Association of Malaysian Helicobacter pylori virulence polymorphisms with severity of gastritis and patients' ethnicity. Helicobacter 2012;17:340-9. [PMID: 22967117 DOI: 10.1111/j.1523-5378.2012.00956.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
26 Zhen-Jun S, Yuan-Yuan Z, Ying-Ying F, Shao-Ju J, Jiao Y, Xiao-Wei Z, Jian C, Yao X, Li-Ming Z. β,β-Dimethylacrylshikonin exerts antitumor activity via Notch-1 signaling pathway in vitro and in vivo. Biochem Pharmacol 2012;84:507-12. [PMID: 22634048 DOI: 10.1016/j.bcp.2012.05.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
27 Malfertheiner MV, Kandulski A, Schreiber J, Malfertheiner P. Helicobacter pylori infection and the respiratory system: a systematic review of the literature. Digestion 2011;84:212-20. [PMID: 21757913 DOI: 10.1159/000329351] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
28 Aghamohammadi A, Abolhassani H, Eibl MM, Espanol T, Kanegane H, Miyawaki T, Mohammadinejad P, Pourhamdi S, Wolf HM, Parvaneh N, Al-herz W, Durandy A, Stiehm ER, Plebani A. Predominantly Antibody Deficiency. Clinical Cases in Primary Immunodeficiency Diseases 2012. [DOI: 10.1007/978-3-642-31785-9_3] [Reference Citation Analysis]
29 Richards CL, Buchholz BJ, Ford TE, Broadaway SC, Pyle BH, Camper AK. Optimizing the growth of stressed Helicobacter pylori. J Microbiol Methods. 2011;84:174-182. [PMID: 21129415 DOI: 10.1016/j.mimet.2010.11.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
30 Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci 2010;55:3124-31. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
31 Geethangili M, Fang S, Lai C, Rao YK, Lien H, Tzeng Y. Inhibitory effect of Antrodia camphorata constituents on the Helicobacter pylori-associated gastric inflammation. Food Chemistry 2010;119:149-53. [DOI: 10.1016/j.foodchem.2009.06.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
32 Chung C, Olivares A, Torres E, Yilmaz O, Cohen H, Perez-Perez G. Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J Clin Microbiol 2010;48:690-6. [PMID: 20053862 DOI: 10.1128/JCM.01815-09] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
33 Altschuler S, Peura DA. Helicobacter Pylori and Peptic Ulcer Disease. GI/Liver Secrets 2010. [DOI: 10.1016/b978-0-323-06397-5.00011-3] [Reference Citation Analysis]
34 Deutsch JC. Gastric Cancer. GI/Liver Secrets 2010. [DOI: 10.1016/b978-0-323-06397-5.00010-1] [Reference Citation Analysis]
35 Cai W, Zhou L, Ren W, Deng L, Yu M. Variables influencing outcome of Helicobacter pylori eradication therapy in South China. Helicobacter 2009;14:91-6. [PMID: 19751433 DOI: 10.1111/j.1523-5378.2009.00718.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
36 Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 2009;124:658-64. [PMID: 19665769 DOI: 10.1016/j.jaci.2009.06.018] [Cited by in Crossref: 98] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
37 Salih BA. Helicobacter pylori infection in developing countries: the burden for how long? Saudi J Gastroenterol 2009;15:201-7. [PMID: 19636185 DOI: 10.4103/1319-3767.54743] [Cited by in Crossref: 103] [Cited by in F6Publishing: 124] [Article Influence: 7.4] [Reference Citation Analysis]
38 Rogers AB, Houghton J. Helicobacter-based mouse models of digestive system carcinogenesis. Methods Mol Biol 2009;511:267-95. [PMID: 19347301 DOI: 10.1007/978-1-59745-447-6_11] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
39 Kountouras J, Zavos C, Diamantidis MD, Deretzi G, Grigoriadis N, Tsapournas G, Katsinelos P, Molyvas E. A concept of Helicobacter pylori and stress-secreted mast cells' potential involvement in brain metastases. Journal of Neuroimmunology 2009;209:121-2. [DOI: 10.1016/j.jneuroim.2009.01.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
40 Rogers AB, Fox JG. Animal Models of Gastric Carcinoma. In: Wang TC, Fox JG, Giraud AS, editors. The Biology of Gastric Cancers. New York: Springer; 2009. pp. 323-59. [DOI: 10.1007/978-0-387-69182-4_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
41 Cheon JH, Kim JH, Lee SK, Kim TI, Kim WH, Lee YC. Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study. Helicobacter 2008;13:564-71. [PMID: 19166423 DOI: 10.1111/j.1523-5378.2008.00647.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
42 Lin YL, Wei CK, Chiang JK, Chou AL, Chen CW, Tseng CE. Concomitant gastric carcinoid and gastrointestinal stromal tumors: A case report. World J Gastroenterol 2008; 14(39): 6100-6103 [PMID: 18932294 DOI: 10.3748/wjg.14.6100] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
43 Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common Variable Immunodeficiency: An Update on Etiology and Management. Immunology and Allergy Clinics of North America 2008;28:367-86. [DOI: 10.1016/j.iac.2008.01.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.0] [Reference Citation Analysis]
44 Yaylali OT, Yilmaz M, Kiraç FS, Degirmencioglu S, Akbulut M. Scintigraphic evaluation of gallbladder motor functions in H pylori positive and negative patients in the stomach with dyspepsia. World J Gastroenterol 2008; 14(9): 1406-1410 [PMID: 18322956 DOI: 10.3748/wjg.14.1406] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]